How a page gets reviewed

Start from the label

Facts come from the current FDA prescribing information, from EMA reviews where they tighten something for the class, and from named trials. Secondary articles are used only to find the primary document. Each profile carries an EM reference from EM-01 to EM-04, and the opening names the warning that comes before any dose: how a prednisone course ends, nitrates with tadalafil, the meal with sildenafil, cardiac rhythm with vardenafil.

Anchor one strength

Each page fixes on one labelled option and stays with it - 2.5 mg prednisone, 5 mg daily or 10 mg as needed, 25 to 100 mg sildenafil, 2.5 to 20 mg vardenafil - so the title, the summary and the body cannot contradict each other. Weak evidence is described as weak. A drug's limits are stated rather than buried. Marketing adjectives are cut. Price tables name licensed US pharmacies, each linking only to that chain, with discount-card services left in the captions.

Vary the middle

Openings and endings stay where they are; the chapters between them are ordered differently on each page, so no two pages here read from the same skeleton.

Physician review

Dr. Marc Vidal reads every draft and writes the reader answers himself. His name stays on the page. What he writes is general teaching and not a plan for any individual reader.

Publish and revisit

Outbound links carry nofollow. The warnings that prevent real harm are repeated where a reader is most likely to land rather than mentioned once at the bottom. Each page shows when it was last reviewed. If something reads out of date, write to [email protected].